Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings
Caitlin M. Dugdale(Harvard University), Andrea Ciaranello(Harvard University), Genevieve G. Fouda(Durham University), Lynda Stranix‐Chibanda(University of Zimbabwe), Christopher Alba(Harvard University), Coleen K. Cunningham(Duke Medical Center), Sallie R. Permar(Cornell University), Valériane Leroy(Université Toulouse III - Paul Sabatier), Kenneth A. Freedberg(Harvard University), Landon Myer(University of Cape Town), Elizabeth J. McFarland(University of Colorado Health), Milton C. Weinstein, Ogochukwu Ufio(Massachusetts General Hospital)
Cited by 20
Related Papers
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
|New England Journal of Medicine|2001|519
Ocular Monkeypox — United States, July–September 2022
|MMWR Morbidity and Mortality Weekly Report|2022|95
Filtration Efficiency, Effectiveness, and Availability of N95 Face Masks for COVID-19 Prevention
|JAMA Internal Medicine|2020|87